Bortezomib inhibits T-cell function versus infective antigenic stimuli in a dose-dependent manner in vitro.
Orciuolo
Enrico
E
Galimberti
Sara
S
Petrini
Mario
M
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001897:Boronic Acids / Q000494:pharmacology*; D000069286:Bortezomib; D003587:Cytomegalovirus / Q000276:immunology*; D004305:Dose-Response Relationship, Drug; D004768:Enterotoxins / Q000276:immunology*; D006801:Humans; D066298:In Vitro Techniques; D011719:Pyrazines / Q000494:pharmacology*; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism
D000970:Antineoplastic Agents; D001897:Boronic Acids; D004768:Enterotoxins; D011719:Pyrazines; C031818:enterotoxin B, staphylococcal; D000069286:Bortezomib